Concepedia
Statistics
Publications
27
Citations
2.3K
H-Index
20
Active since
1983
Affiliations
Virginia BioTechnology Research Park(Current)
Janssen (United States)
WuXi AppTec (China)
Exelixis (United States)
BD Biosciences (United States)
Kenneth J. Shaw is an author at Virginia BioTechnology Research Park specializing in medicine, drug discovery, and pharmacology.
Top concepts
MedicinePharmacologyDrug DiscoveryMedicinal ChemistryNatural SciencesBiochemistryDrug DevelopmentPharmacotherapyOrganic ChemistryChemical Biology
Publications per year
1983–2020
Systematic generation of high-resolution deletion coverage of the Drosophila melanogaster genome
Annette L. Parks, Kevin R Cook, Marcia Belvin et al. · Nature Genetics · 2004 · 770 citations · Full text
Biology, Drosophila Melanogaster Genome, Genetics +8
Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy.
Diane Pennica, K. L. King, Kenneth J. Shaw et al. · Proceedings of the National Academy of Sciences · 1995 · 556 citations · Full text
Cardiac Muscle, Heart Failure, Expression Cloning +22
Routes to mitomycins. Chirospecific synthesis of aziridinomitosenes
Kenneth J. Shaw, Jay R. Luly, Henry Rapoport · The Journal of Organic Chemistry · 1985 · 139 citations
Pharmaceutical Science, Bioorganic Chemistry, Engineering +16
Design, synthesis, and in vitro biological activity of benzimidazole based factor Xa inhibitors
Zuchun Zhao, Damian O. Arnaiz, Brian D. Griedel et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 104 citations · Full text
Medicinal Chemistry, Biochemistry, Antiparasitic Agent +9
Discovery of XL413, a potent and selective CDC7 inhibitor
Elena S. Koltun, Amy Lew Tsuhako, David S. Brown et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 90 citations · Full text
Medicinal Chemistry, Drug Target, Selective Cdc7 Inhibitor +5
1–5 of 27